Your browser doesn't support javascript.
loading
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray, Kausik K; Colhoun, Helen M; Szarek, Michael; Baccara-Dinet, Marie; Bhatt, Deepak L; Bittner, Vera A; Budaj, Andrzej J; Diaz, Rafael; Goodman, Shaun G; Hanotin, Corinne; Harrington, Robert A; Jukema, J Wouter; Loizeau, Virginie; Lopes, Renato D; Moryusef, Angèle; Murin, Jan; Pordy, Robert; Ristic, Arsen D; Roe, Matthew T; Tuñón, José; White, Harvey D; Zeiher, Andreas M; Schwartz, Gregory G; Steg, Philippe Gabriel.
Afiliação
  • Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London, UK. Electronic address: k.ray@imperial.ac.uk.
  • Colhoun HM; University of Edinburgh, Edinburgh, Scotland, UK.
  • Szarek M; State University of New York, Downstate School of Public Health, Brooklyn, NY, USA.
  • Baccara-Dinet M; Sanofi, Montpellier, France.
  • Bhatt DL; Heart & Vascular Center, Brigham and Women's Hospital Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Budaj AJ; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland.
  • Diaz R; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina.
  • Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada; St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Hanotin C; Sanofi, Paris, France.
  • Harrington RA; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Jukema JW; Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.
  • Loizeau V; Sanofi, Paris, France.
  • Lopes RD; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA; Duke University, Durham, NC, USA.
  • Moryusef A; Sanofi, Bridgewater, NJ, USA.
  • Murin J; 1st Internal Department, Comenius University, University Hospital, Bratislava, Slovakia.
  • Pordy R; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Ristic AD; Department of Cardiology, Clinical Center of Serbia, Belgrade University School of Medicine, Belgrade, Serbia.
  • Roe MT; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
  • Tuñón J; Fundación Jiménez Díaz, Madrid, Spain.
  • White HD; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand.
  • Zeiher AM; Department of Medicine III, Goethe University, Frankfurt, Germany.
  • Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Steg PG; National Heart and Lung Institute, Royal Brompton Hospital, Imperial College London, London, UK; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université de Paris, FACT (French Alliance for Cardiovascular Trials), INSERM U1148, Paris, France.
Lancet Diabetes Endocrinol ; 7(8): 618-628, 2019 08.
Article em En | MEDLINE | ID: mdl-31272931
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Complicações do Diabetes / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Complicações do Diabetes / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article